HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gubern, C. Articles by Fernández-Real, J. M. Search for Related Content PubMed PubMed Citation Articles by Gubern, C. Articles by Fernández-Real, J. M. Social Bookmarking                What's this?

Natural Antibiotics and Insulin Sensitivity

The Role of Bactericidal/Permeability-Increasing Protein

¹ Section of Diabetes, Endocrinology and Nutrition, Institut d’Investigació Biomédica de Girona, Girona, Spain
² Research Unit, University Hospital of Tarragona "Joan XXIII," Institut Pere Virgili, Tarragona, Spain

Address correspondence and reprint requests to J.M. Fernández-Real, MD, PhD, Unit of Diabetes, Endocrinology and Nutrition, Hospital de Girona "Dr. Josep Trueta," Ctra. França s/n, 17007 Girona, Spain. E-mail: uden.jmfernandezreal{at}htrueta.scs.es

Abbreviations: BPI, bactericidal/permeability-increasing protein; CIGMA, continuous infusion of glucose with model assessment; ELISA, enzyme-linked immunosorbent assay; HOMA, homeostasis model assessment; LBP, lipopolysaccharide-binding protein; sTNFR, soluble fraction of tumor necrosis factor- receptor; UTR, untranslated region

The innate immune system can immediately respond to microorganism intrusion by helping to prevent further invasion. Bactericidal/permeability-increasing protein (BPI) is a major constituent of neutrophils that possesses anti-inflammatory properties. Inflammation is increasingly recognized as a component of the metabolic syndrome. We hypothesized that the production of BPI could be linked to insulin sensitivity and glucose tolerance. We studied circulating BPI across categories of glucose tolerance. We also studied whether these cross-sectional associations were of functional importance. For this reason, we investigated circulating bioactive lipopolysaccharide and the effects of changing insulin action—after treatment with an insulin sensitizer (metformin)—on circulating BPI in subjects with glucose intolerance. Finally, we tested whether a 3'-untranslated region (UTR) BPI polymorphism led to differences in BPI and insulin action among nondiabetic subjects. Age- and BMI-adjusted circulating BPI was significantly lower among patients with type 2 diabetes. Circulating BPI correlated negatively with fasting and postload glucose and insulin concentrations. In subjects with glucose intolerance, BPI was also linked to BMI, waist-to-hip ratio, and age- and BMI-adjusted insulin sensitivity. Bioactive lipopolysaccharide was negatively correlated with circulating BPI (r = –0.57, P < 0.0001) and positively with plasma lipopolysaccharide-binding protein (r = 0.54, P = 0.002). In parallel to improved insulin sensitivity, plasma BPI significantly increased in the metformin group but not in the placebo group. A 3'-UTR BPI polymorphism was simultaneously associated with plasma BPI concentration, waist-to-hip ratio, fasting and postload insulin concentration, fasting plasma triglycerides, and insulin sensitivity. These findings suggest that this component of the innate immune system is associated with metabolic pathways.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Fernandez-Real, J. M. Moreno, and W. Ricart Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance-Associated Iron Overload Diabetes, July 1, 2008; 57(7): 1918 - 1925. [Abstract] [Full Text] [PDF]

				M. Broch, J. Vendrell, W. Ricart, C. Richart, and J.-M. Fernandez-Real Circulating Retinol-Binding Protein-4, Insulin Sensitivity, Insulin Secretion, and Insulin Disposition Index in Obese and Nonobese Subjects Diabetes Care, July 1, 2007; 30(7): 1802 - 1806. [Abstract] [Full Text] [PDF]

				A. Lopez-Bermejo, B. Chico-Julia, A. Castro, M. Recasens, E. Esteve, J. Biarnes, R. Casamitjana, W. Ricart, and J.-M. Fernandez-Real Alpha Defensins 1, 2, and 3: Potential Roles in Dyslipidemia and Vascular Dysfunction in Humans Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1166 - 1171. [Abstract] [Full Text] [PDF]

				J. M. Fernandez-Real, J. M. Moreno, A. Lopez-Bermejo, B. Chico, J. Vendrell, and W. Ricart Circulating Soluble Transferrin Receptor According to Glucose Tolerance Status and Insulin Sensitivity Diabetes Care, March 1, 2007; 30(3): 604 - 608. [Abstract] [Full Text] [PDF]

				M. Manco, J. M. Fernandez-Real, F. Equitani, J. Vendrell, M. E. Valera Mora, G. Nanni, V. Tondolo, M. Calvani, W. Ricart, M. Castagneto, et al. Effect of Massive Weight Loss on Inflammatory Adipocytokines and the Innate Immune System in Morbidly Obese Women J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 483 - 490. [Abstract] [Full Text] [PDF]